JP2002538110A5 - - Google Patents

Download PDF

Info

Publication number
JP2002538110A5
JP2002538110A5 JP2000602059A JP2000602059A JP2002538110A5 JP 2002538110 A5 JP2002538110 A5 JP 2002538110A5 JP 2000602059 A JP2000602059 A JP 2000602059A JP 2000602059 A JP2000602059 A JP 2000602059A JP 2002538110 A5 JP2002538110 A5 JP 2002538110A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
dispersion
dry powder
pharmaceutically acceptable
aerosol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000602059A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002538110A (ja
Filing date
Publication date
Priority claimed from GBGB9904919.9A external-priority patent/GB9904919D0/en
Application filed filed Critical
Publication of JP2002538110A publication Critical patent/JP2002538110A/ja
Publication of JP2002538110A5 publication Critical patent/JP2002538110A5/ja
Withdrawn legal-status Critical Current

Links

JP2000602059A 1999-03-03 2000-03-01 喘息用のフォルモテロールおよびモメタゾンフロエートの組合せ Withdrawn JP2002538110A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9904919.9 1999-03-03
GBGB9904919.9A GB9904919D0 (en) 1999-03-03 1999-03-03 Organic compounds
PCT/EP2000/001722 WO2000051591A1 (en) 1999-03-03 2000-03-01 Combinations of formoterol and mometasone furoate for asthma

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009174025A Division JP5646828B2 (ja) 1999-03-03 2009-07-27 喘息用のフォルモテロールおよびモメタゾンフロエートの組合せ

Publications (2)

Publication Number Publication Date
JP2002538110A JP2002538110A (ja) 2002-11-12
JP2002538110A5 true JP2002538110A5 (https=) 2008-05-01

Family

ID=10848904

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2000602059A Withdrawn JP2002538110A (ja) 1999-03-03 2000-03-01 喘息用のフォルモテロールおよびモメタゾンフロエートの組合せ
JP2009174025A Expired - Lifetime JP5646828B2 (ja) 1999-03-03 2009-07-27 喘息用のフォルモテロールおよびモメタゾンフロエートの組合せ
JP2013010543A Expired - Lifetime JP5663046B2 (ja) 1999-03-03 2013-01-23 喘息用のフォルモテロールおよびモメタゾンフロエートの組合せ

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2009174025A Expired - Lifetime JP5646828B2 (ja) 1999-03-03 2009-07-27 喘息用のフォルモテロールおよびモメタゾンフロエートの組合せ
JP2013010543A Expired - Lifetime JP5663046B2 (ja) 1999-03-03 2013-01-23 喘息用のフォルモテロールおよびモメタゾンフロエートの組合せ

Country Status (27)

Country Link
US (4) US20020055494A1 (https=)
EP (2) EP1325765A1 (https=)
JP (3) JP2002538110A (https=)
KR (1) KR100682418B1 (https=)
CN (1) CN1196478C (https=)
AT (1) ATE241970T1 (https=)
AU (1) AU770739B2 (https=)
BR (1) BR0008699A (https=)
CA (1) CA2362499C (https=)
CL (1) CL2004001170A1 (https=)
CZ (1) CZ294089B6 (https=)
DE (1) DE60003160T2 (https=)
DK (1) DK1156790T3 (https=)
ES (1) ES2200837T3 (https=)
GB (1) GB9904919D0 (https=)
HK (1) HK1043048B (https=)
HU (1) HU229073B1 (https=)
ID (1) ID30171A (https=)
IL (1) IL144351A (https=)
NO (1) NO331428B1 (https=)
NZ (1) NZ513742A (https=)
PL (1) PL212355B1 (https=)
PT (1) PT1156790E (https=)
RU (1) RU2270670C2 (https=)
SK (1) SK286338B6 (https=)
WO (1) WO2000051591A1 (https=)
ZA (1) ZA200106442B (https=)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
GB9904919D0 (en) * 1999-03-03 1999-04-28 Novartis Ag Organic compounds
GB9928311D0 (en) * 1999-11-30 2000-01-26 Novartis Ag Organic compounds
GB0009612D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Therapeutic formulations
GB0012260D0 (en) 2000-05-19 2000-07-12 Astrazeneca Ab Novel composition
AU2001278115A1 (en) * 2000-08-04 2002-02-18 Longwood Pharmaceutical Research, Inc. Formulations of mometasone and a bronchodilator for pulmonary administration
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
TWI324934B (en) * 2001-08-28 2010-05-21 Schering Corp Pharmaceutical compositions for the treatment of asthma
EP3384931B1 (en) * 2002-03-01 2019-07-24 Chiesi Farmaceutici S.p.A. Formoterol superfine formulation
GB0207906D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and mometasone aerosol formulations
DK1542904T3 (da) * 2002-08-27 2008-04-21 Schering Corp Fremgangsmåde til fremstilling af formuleringer til en inhalator med målte doser
US20040043064A1 (en) * 2002-08-29 2004-03-04 Iorio Theodore L. Dosage forms having reduced moisture transmission
SE527200C2 (sv) * 2003-06-19 2006-01-17 Microdrug Ag Inhalatoranordning samt kombinerade doser av formaterol och fluticason
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
CA2540005A1 (en) * 2003-09-26 2005-04-07 Schering Corporation Pulmonary disease treatment
GB0323684D0 (en) 2003-10-09 2003-11-12 Jagotec Ag Improvements in or relating to organic compounds
KR20060106823A (ko) * 2003-10-20 2006-10-12 쉐링 코포레이션 약제학적 에어로졸 조성물
EP1680084A2 (en) * 2003-10-21 2006-07-19 Direct-Haler A/S A multiple route medication for the treatment of rhinitis and asthma
EP2484382A1 (en) * 2005-03-30 2012-08-08 Schering Corporation Medicament comprising a phosphodiesterase IV inhibitor in an inhalable form
US20070099883A1 (en) * 2005-10-07 2007-05-03 Cheryl Lynn Calis Anhydrous mometasone furoate formulation
WO2007059620A1 (en) * 2005-11-23 2007-05-31 Feanny Stephen J Method for administering formoterol using a nebulizer
US20080253970A1 (en) * 2007-02-09 2008-10-16 Schering Corporation Stable Pharmaceutical Drug Products
US20080294720A1 (en) * 2007-05-21 2008-11-27 International Business Machines Corporation Enhanced Online Collaboration System
US8898316B2 (en) * 2007-05-30 2014-11-25 International Business Machines Corporation Enhanced online collaboration system for viewers of video presentations
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
MX337126B (es) 2009-05-29 2016-02-12 Pearl Therapeutics Inc Administracion respiratoria de agentes activos.
GB0918149D0 (en) 2009-10-16 2009-12-02 Jagotec Ag Improved medicinal aerosol formulation
WO2011093815A2 (en) * 2010-01-29 2011-08-04 Mahmut Bilgic Pharmaceutical compositions comprising formoterol and mometasone
US20130177651A1 (en) * 2010-09-03 2013-07-11 Pharmaterials Limited Pharmaceutical Composition Suitable for Use in a Dry Powder Inhaler
CN102416179B (zh) 2010-09-28 2014-05-07 益得生物科技股份有限公司 用于哮喘的吸入性复方组合物
GB201113662D0 (en) * 2011-08-08 2011-09-21 Prosonix Ltd Pharmaceutical compositions
WO2014007771A2 (en) 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Inhalation compositions comprising muscarinic receptor antagonist
WO2014007772A2 (en) * 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Inhalation compositions comprising glucose anhydrous
KR102391332B1 (ko) 2013-03-15 2022-04-26 펄 테라퓨틱스 인코포레이티드 미립자 결정질 재료를 컨디셔닝하는 방법 및 시스템
ITMI20130571A1 (it) * 2013-04-10 2014-10-11 Zambon Spa Composizione farmaceutica contenente budesonide e formoterolo
US9427376B2 (en) * 2013-10-10 2016-08-30 Chiesi Farmaceutici S.P.A. Process for preparing pharmaceutical formulations for inhalation comprising a high-dosage strength active ingredient
KR102449403B1 (ko) * 2014-10-08 2022-09-29 잠본쏘시에떼퍼아찌오니 부데소니드 및 포르모테롤을 함유하는 약학 조성물
GB2545025A (en) * 2015-12-04 2017-06-07 Mexichem Fluor Sa De Cv Pharmaceutical composition
EP3556348B1 (en) 2015-12-04 2021-02-03 Mexichem Fluor S.A. de C.V. Pharmaceutical composition
CN115813935A (zh) * 2021-09-16 2023-03-21 上海上药信谊药厂有限公司 药物组合物、气雾剂及其制备方法和气雾剂产生系统
CN116763797B (zh) * 2022-03-09 2025-09-02 上海医药工业研究院有限公司 一种药物组合微球、其制备方法及其原料组合物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL95590A (en) 1989-09-08 1996-06-18 Glaxo Group Ltd Medicinal preparations containing Salmetrol and Pluticasone Propionate
SE9302777D0 (sv) * 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
US5874063A (en) * 1991-04-11 1999-02-23 Astra Aktiebolag Pharmaceutical formulation
ES2172510T3 (es) 1991-12-18 2002-10-01 Astrazeneca Ab Nueva combinacion de formoterol y budesonida.
US6596260B1 (en) 1993-08-27 2003-07-22 Novartis Corporation Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol
PE44995A1 (es) 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
US5837699A (en) * 1994-01-27 1998-11-17 Schering Corporation Use of mometasone furoate for treating upper airway passage diseases
EP0806940B1 (en) 1994-12-22 2003-04-09 AstraZeneca AB Aerosol drug formulations
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
AU718967B2 (en) * 1997-02-05 2000-05-04 Jagotec Ag Medical aerosol formulations
DK0969816T3 (da) * 1997-03-20 2005-03-14 Schering Corp Fremstilling af pulveragglomerater
EP1033991B1 (en) * 1997-10-09 2002-04-17 Schering Corporation Mometasone furoate suspensions for nebulization
MY133181A (en) * 1998-09-10 2007-10-31 Schering Corp Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines
GB9904919D0 (en) * 1999-03-03 1999-04-28 Novartis Ag Organic compounds
TWI324934B (en) * 2001-08-28 2010-05-21 Schering Corp Pharmaceutical compositions for the treatment of asthma

Similar Documents

Publication Publication Date Title
JP2002538110A5 (https=)
RU2001126347A (ru) Композиции, включающие формотерол и фуроат мометасона, предназначенные для лечения астмы
RU2001123923A (ru) Композиции, включающие формотерол и соль тиотропия
JP5952231B2 (ja) ドラッグ・デリバリー用の安定な金属イオン−脂質粉末状医薬組成物とその利用方法
CN101181263B (zh) 呼吸系统疾病的治疗药物
EP0386232B1 (en) Nasal administration of benzodiazepine hypnotics
JP2022180461A5 (https=)
RU2002116251A (ru) Аэрозольная композиция, содержащая формотерол
JP2004514739A5 (https=)
JP2002519318A5 (https=)
CA2427282A1 (en) Mixtures or organic compounds for the treatment of airway diseases
SI9200403B (en) New combination of a bronchodilator and a steroidal antiinflammatory drug for treatment of respiratory disorders as well as its use and preparation thereof
JP2002528399A (ja) Δ９テトラヒドロカナビノール（δ９ｔｈｃ）溶液計量ずみ投与量吸入器および使用方法
BR0303348A (pt) Formulações de aerossol para administração pulmonar de medicamentos com o intuito de produzir efeito sistêmico
JP2005515966A5 (https=)
KR970704422A (ko) 투여용 약제학적 조성물
CA2277365A1 (en) Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1
FI2265257T4 (fi) Aklidiniumia käsittävä inhalaatiokoostumus kroonisen keuhkoahtaumataudin hoitamiseksi
RU2008124825A (ru) Органические соединения, включающие соль гликопиррония
IE914498A1 (en) Treatment of cystic fibrosis and pharmaceutical compositions¹for use therein
RU2005135133A (ru) Фармацевтические композиции
WO2002028368A1 (en) New combination for the treatment of asthma
JP2004529108A5 (https=)
CA2701956A1 (en) Combination therapy
JPH11106339A (ja) Ｃｒ２０３９を含有する吸入用医薬組成物